Lead vaccine candidates developed by Oxford University and Moderna, against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo, could enter Phase 1 trials as early as July, with field trials possible within several months, the head of the Coalition for Epidemic Preparedness Innovations, Richard Hatchett, said on Tuesday.
Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July
A healthcare worker at the Bunia General Referral Hospital following a resurgence of Ebola involving the Bundibugyo strain, a rarer variant of the virus with no approved vaccine currently available, in Bunia, Ituri province of the Democratic Republic of Congo. Image credits: Reuters.
&uuid=(email))